Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

304.90

-11.55 (-3.65%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

304.90

-11.55 (-3.65%)
16:02 Dec 20

Quality

55/100
High Financial Strength

Valuation

28/100
Expensive Valuation

Technical

67/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1376.18	1490.84	1852.14	2177.41	2378.68
Operating Expenses +	1036.57	1231.95	1512.82	1718.83	1871.92
Raw Material	731.33	703.92	927.75	1111.98	1262.79
Increase Decrease in Cost	-136.28	12.9	-6.39	-73.86	-199.96
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	197.32	220.3	239.37	293.64	318.92
Miscellaneous Expenses	867.34	621.33	981.65	1275.63	490.17
Operating Profit	339.61	258.89	339.32	458.58	506.76
Other Income	6.69	41.85	59.31	50.42	47.34
Depreciation	36.15	44.78	51.85	74.27	83.01
Interest	7.99	8.45	9.13	11.2	13.55
Profit before tax and exceptio..	302.16	247.51	337.65	423.53	457.54
Exceptional Items	0	0	0	0	0
PBT	302.16	247.51	337.65	423.53	457.54
Provision for Taxation	63.63	60.7	72.33	108.63	110.11
Net Profit	238.54	186.81	265.32	314.9	347.43
NET Profit after MI	238.54	186.81	266.31	313.7	347
EPS	5.76	4.51	6.41	6.92	7.66
Operating Profit Margin (%)	24.68	17.37	18.32	21.06	21.3
Net Profit Margin (%)	17.33	12.53	14.38	14.41	14.59

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	43.90	43.90	43.80	43.80	43.80
FII	21.30	18.60	15.60	15.60	15.10
MF	3.00	2.80	4.20	3.80	3.20
Public	30.70	33.80	35.40	35.80	37.10
Others	0.00	0.00	0.10	0.10	0.00
Others	1.10	0.90	0.90	0.90	0.80